Mark Genovese

Back to Profile

Publication Details

  • Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients.

    Genovese MC, Breedveld FC, Emery P, Cohen S, Keystone E, Matteson EL, Baptiste Y, Chai A, Burke L, Reiss W, Sweetser M, Shaw TM. Ann Rheum Dis. 2009; 68 (12): 1894-7

    To assess the safety of biological disease-modifying antirheumatic drugs (DMARD) in rheumatoid arthritis (RA) patients following rituximab.

    PubMedID: 19155233

Stanford Medicine Resources:

Footer Links: